Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
STTK

STTK - Shattuck Labs Inc Stock Price, Fair Value and News

$4.18+0.16 (+3.98%)
Market Closed

15/100

STTK

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

15/100

STTK

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$3.32

Target 3M

$3.74

Target 6M

$3.53

STTK Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

STTK Price Action

Last 7 days

-5.9%

Last 30 days

19.4%

Last 90 days

117.7%

Trailing 12 Months

254.2%

STTK RSI Chart

STTK Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

STTK Valuation

Market Cap

264.5M

Price/Earnings (Trailing)

-4.82

Price/Sales (Trailing)

47.18

Price/Free Cashflow

-2.51

STTK Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$3.32

Target 3M

$3.74

Target 6M

$3.53

STTK Fundamentals

STTK Revenue

Revenue (TTM)

5.6M

Rev. Growth (Yr)

-66.63%

STTK Earnings

Earnings (TTM)

-54.9M

Earnings Growth (Yr)

39.69%

Earnings Growth (Qtr)

19.28%

STTK Profitability

Return on Equity

-58.87%

Return on Assets

-54.71%

Free Cashflow Yield

-39.77%

STTK Investor Care

Shares Dilution (1Y)

32.55%

Diluted EPS (TTM)

-1.02

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2025005.6M0
20242.7M4.1M6.4M5.7M
2023755.5K859.0K1.3M1.7M
2022020.2M10.4M652.0K
20219.2M07.9M30.0M
20209.9M9.9M9.9M9.9M
20190009.9M
Get all data in R, Python etc through our Historical Stock Data APIs

About Shattuck Labs Inc

STTK
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. The company was incorporated in 2016 and is headquartered in Austin, Texas.
 CEO
 WEBSITEshattucklabs.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES105

Shattuck Labs Inc Frequently Asked Questions

STTK is the stock ticker symbol of Shattuck Labs Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Shattuck Labs Inc is 264.51 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check STTK's fair value in chart for subscribers.

The fair value guage provides a quick view whether STTK is over valued or under valued. Whether Shattuck Labs Inc is cheap or expensive depends on the assumptions which impact Shattuck Labs Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for STTK.

As of Wed Jan 28 2026, STTK's PE ratio (Price to Earnings) is -4.82 and Price to Sales (PS) ratio is 47.18. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. STTK PE ratio will change depending on the future growth rate expectations of investors.